Skip to main content
Annals of African Medicine logoLink to Annals of African Medicine
. 2026 Feb 6;25(6):1699–1706. doi: 10.4103/aam.aam_377_25

A Comparative Analysis of the Efficacy of CD117 and Special Stains as Indicators of Mechanical Asphyxial Deaths

Raghvendra Singh Shekhawat 1,✉, Rahul Panwar 1, Meenakshi Rao 1, Vikas Premlal Meshram 1, Meena Suresh Kumar 1, Sridevi Gnanasekaran 2, Mohini Rathore 3, Tanuj Kanchan 1
PMCID: PMC13645296  PMID: 41656301

Abstract

Background:

Determining the cause of death in suspected asphyxia is often difficult when external findings are absent. Mast cells (MCs) may provide objective histological evidence of hypoxia.

Objective:

To compare the efficacy of immunohistochemistry (IHC) using CD117 with Toluidine Blue (TB) and Giemsa (GM) stains in detecting mast cells in asphyxial and non-asphyxial lung tissues.

Materials and Methods:

Lung samples from 164 medicolegal autopsies at AIIMS Jodhpur were studied, 57 asphyxial and 107 non-asphyxial deaths. Peribronchial and perialveolar regions were examined using TB, GM, and IHC (CD117). Mean mast cell counts were compared using Mann–Whitney U and Kruskal-Wallis tests.

Results:

Mast cell counts were significantly higher in asphyxial cases. Peribronchial counts: IHC 2.27 ± 1.02, TB 2.29 ± 1.19, GM 0.84 ± 0.59. Perialveolar counts: IHC 0.74 ± 0.12, TB 0.10 ± 0.19, GM 0.01 ± 0.51. IHC was more sensitive than GM (P < 0.001), while TB showed comparable efficacy to IHC.

Conclusion:

CD117-based IHC is the most sensitive method for identifying mast cells in asphyxial lungs, though TB remains a valuable low-cost option. Mast cell analysis can serve as an adjunct marker in diagnosing mechanical asphyxia.

Keywords: Asphyxia, forensic pathology, histopathology, immunohistochemistry, lungs, mast cells

INTRODUCTION

Asphyxia-related deaths are regularly encountered by forensic pathologists, and many times, ascertaining the cause of death is not a substantial challenge.[1,2] In the prevailing forensic pathology services, the collaborative teamwork of the forensic pathologist and law enforcement agencies often forms the core of investigative procedures. The importance of the crime scene analysis cannot be lesser emphasized. While certain macroscopic signs, such as strangulation marks, cyanosis, petechial hemorrhage, and lung edema, can provide valuable insights, there can be situations in which, due to the paucity of these gross findings, it becomes difficult to conclude the cause of death.[3] In such ambiguous situations, a forensic pathologist may require additional ancillary investigations, such as histopathological examination and postmortem thanatobiochemical techniques. However, these subsidiary investigations may prove to be of adjunct importance in concluding a diagnosis of asphyxia.

Recent studies have underscored the significant role of histopathological investigation, especially the examination of mast cells (MCs), in identifying the cause of death in cases of suspected mechanical asphyxia.[4] MCs are highly abundant producers of enzymes that break down proteins, including specific proteases such as tryptase, carboxypeptidase A, and chymase. In hypoxia, MCs play a crucial role in restructuring pulmonary arteries.[,6,7,8] Their involvement in asphyxia-induced pathophysiological processes has garnered attention from forensic pathologists seeking additional objective markers to support their conclusions.

MCs are present in human lung tissues, the pulmonary epithelium, and the bronchial lumen. These cells contain secretory granules in which specific mediators are stored and released in response to acute asphyxia. Acute asphyxia has been shown to trigger increased MC activity and degranulation in many studies. This response may be attributed to the hypoxic conditions and mechanical stress experienced by the tissues during the event.[,10,11,12] Thus, MC analysis may help explain asphyxial fatalities. Histopathologists use specific stains, such as toluidine blue (TB), GM, hematoxylin–eosin, and Oil Red O (also known as Sudan III-red-B-stain), to demonstrate MCs in both antemortem and postmortem specimens. MCs are typically stained with TB and GM. TB stains tissue purple to red, and the backdrop appears blue, whereas the GM stain shows MCs in purple.[13]

Immunohistochemistry (IHC) utilizes precise antibody–antigen interactions to locate and identify antigens in cells and tissues. These antigens are found and analyzed using this method. IHC markers can identify and characterize MCs in postmortem tissue samples. CD117 (c-kit) is one of the common IHC markers employed for analyzing the distribution and characterization of MCs in clinical and forensic practice.[14] IHC staining targeting CD117 allows for the specific identification and quantification of MCs, providing objective data that can assist forensic pathologists in determining the cause of death in suspicious asphyxial cases.[,16,17,18,19,20,21,22]

The present study has employed IHC using the CD117 marker and special stains, such as TB and GM stains, which may assist in determining the cause of death in asphyxial deaths with ambiguous findings, depending on the investigation circumstances. This study will explore the role of MCs in hypoxia pathophysiology and examine the application of histological methods in forensic investigations.

A statistical comparative analysis is also conducted in the present study to highlight the efficacy of the techniques mentioned above, considering the accuracy and cost-effectiveness of these techniques in resource-limited settings.

MATERIALS AND METHODS

The research was conducted in the Department of Forensic Medicine and the Department of Pathology and Laboratory Medicine at All India Institute of Medical Sciences (AIIMS), Jodhpur (India). Approval was sought from the institutional ethics committee vide approval no. (AIIMS/IEC/2017/370). The research included a total of 164 instances involving medicolegal autopsies. Lung tissue specimens were collected from deceased human individuals at the AIIMS mortuary facility in Jodhpur. Informed consent was obtained from the next of kin.

The cases were divided into two groups. Asphyxia cases made up the first group (total n = 57: hanging (n = 50), drowning (n = 2), postural asphyxia (n = 1), strangulation (n = 2), smothering (n = 2). 107 fatalities, which were represented as control cases [total n = 107: road crashes (n = 37); railway traffic accidents (n = 18); sudden death (n = 30); head injury (n = 5); fall from height (n = 3); poisoning (n = 7); electrocution (n = 4); burns (n = 2); transfusion lungs injury (n = 1)]. Cases with pulmonary pathologies, such as diffuse alveolar damage, bronchiolitis, pulmonary hemorrhage, and pulmonary edema, were excluded from the study. We examined gross lung edema and petechial hemorrhages in the case and control groups. Cases with these findings were included, and controls with the same findings were excluded from the study. The cases with a history of atopy/hypersensitivity were also excluded from the study. Only cases in which the time between death and sample collection was <48 h were used to decrease the impact of autolytic changes as a confounding factor.

Histopathological examination using special stains

The right and left lung tissue from each case was received in 10% neutral buffered formalin (NBF). Representative tissue slices were prepared in an automated Leica tissue processor. Leica’s automated slide stainer treated 4–5 µ tissue slices with hematoxylin and eosin (H and E) stain. To highlight MCs, representative slices were manually stained with TB. TB stain was prepared using a TB stock solution (pH: 2–2.5) and sodium chloride (1%). The staining procedure involved deparaffinizing and hydrating sections in distilled water, staining them for 2–3 min, washing them in distilled water, dehydrating them quickly with 95% ethanol and two changes of 100% ethanol, and clearing them in xylene. The staining was then covered with mounting media.

GM stain was prepared using a stock solution of glycerol, methanol, and 3.89 g of GM powder. The stock solution was used after 2 weeks. The GM working solution was prepared by mixing a stock solution and distilled water in a ratio of 1:9. The staining procedure involved deparaffinizing and hydrating sections with water, staining them for 8–10 min, washing them with tap water, and then drying and mounting the stained slide. The microscope was used to examine the presence and number of MCs in five fields, each with a diameter of 0.65 mm and a field area of 0.332 mm2, and was recorded at ×400. The mean MC count per field was calculated.

Immunohistochemical analysis

Lung tissue samples from each lobe’s peribronchial and perialveolar regions in each case were fixed in a 10% NBF solution and cut into 5-μm slices from each paraffin-embedded block. Nikon Eclipse (Model Eclipse Ci-L) microscopes analyzed lungs from all asphyxial and nonasphyxial fatalities. Representative H and E-stained sections from all patients were chosen for IHC. IHC slides were poly-L-lysine-coated. Polyclonal rabbit antihuman CD117, c-kit (Dako, code A4502) antibody was diluted 1:500 and utilized in an automated IHC stainer, Leica Bond-Max, with diaminobenzidine substrate chromogen solution. The pathologist blindly examined IHC slides to determine the cause of death. All instances had MC CD117 IHC-positive sections. MCs expressed CD117 both cytoplasmically and on their membranes. MCs were examined in the perialveolar and peribronchial regions. The mean MC counts in five random microscopic fields, each with a diameter of 0.65 mm and a field area of 0.332 mm2, were recorded at ×400.

Statistical analysis

Data were recorded in Microsoft Office Excel Sheet 2019 (Microsoft Corporation, Redmond, WA, USA) and were analyzed and processed using IBM SPSS Statistics for Windows, Version 26.0 (IBM Corp., Armonk, NY, USA). software.

RESULTS

Table 1 shows that the mean MC count in the lungs’ peribronchial region of asphyxial fatalities using IHC (2.270) was significantly higher than in nonasphyxial deaths (0.310), with asphyxial deaths exhibiting a significantly higher variability in MC counts (standard deviation [SD]: 1.027) compared to nonasphyxial deaths (SD: 0.372). TB staining revealed that the mean MC count in asphyxial deaths (2.288) was significantly higher than in nonasphyxial deaths (0.241), with asphyxial deaths showing higher variability in MC counts (SD: 1.193) compared to nonasphyxial deaths (SD: 0.318). GM-stained asphyxial fatalities had a mean MC count of 0.839, compared to 0.099 in nonasphyxial deaths. Asphyxial deaths exhibited significantly greater variability in MC counts (SD: 0.595) than nonasphyxial deaths (SD: 0.218). IHC, TB, and GM stain MCs in the perialveolar area of asphyxial and nonasphyxial fatalities [Table 1]. Asphyxial fatalities using IHC had a higher perialveolar MC count (0.740) than nonasphyxial deaths (0.022), with asphyxial deaths had a higher MC count variability (SD: 0.123) than nonasphyxial deaths (SD: 0.063). TB staining of asphyxial deaths had a higher mean MC count in the perialveolar area (0.105) than nonasphyxial deaths (0.024), with asphyxial deaths had higher MC count variability (SD: 0.196) than nonasphyxial deaths (SD: 0.065). GM stain MCs demonstrated that asphyxial fatalities had a higher perialveolar MC count (0.014) than nonasphyxial deaths (0), and asphyxial fatalities had a higher MC count variability (SD: 0.515) than nonasphyxial deaths (SD: 0).

Table 1.

Descriptive statistics of immunohistochemistry, toluidine blue, and Giemsa stain mast cells in the peribronchial and perialveolar area of asphyxia and nonasphyxial deaths

Region Staining method Group n Range Meanein
PB IHC mast cells Asphyxial 57 0.2hyxi 2.270x1.027
IHC mast cells Nonasphyxial 107 0.2asph 0.310phyxia
PB TB mast cells Asphyxial 57 0.0hyxi 2.288xialel
TB mast cells Nonasphyxial 107 0.0asph 0.241phyxia
PB GM mast cells Asphyxial 57 0.0hyxi 0.839xialel
GM mast cells Nonasphyxial 107 0.0asph 0.099phyxia
Perialveolar IHC mast cells Asphyxial 57 0.0hyxi 0.740xialls
IHC mast cells Nonasphyxial 107 0.0asph 0.022phyxia
Perialveolar TB mast cells Asphyxial 57 0.0hyxi 0.105xialel
TB mast cells Nonasphyxial 107 0.0asph 0.024phyxia
Perialveolar GM mast cells Asphyxial 57 0.0hyxi 0.014xialel
GM mast cells Nonasphyxial 107 0.0asph 0.000phyxia

n=Number of samples from each lung, SD=Standard deviation, TB=Toluidine blue staining, IHC=Immunohistochemistry, GM=Giemsa staining, PB=Peribronchial tissue

Mann–Whitney U-test results, as shown in Table 2, reveal the difference in MC visualization between three staining techniques: IHC, TB, and GM in cases of asphyxial death. There was no significant difference in the staining of IHC and TB within the peribronchial area, as indicated by a Z-score of − 0.051 and P = 0.959. The mean ranks were 57.34 for IHC and 57.66 for TB, reflecting that the two techniques perform equally well in visualizing MCs in this region. However, there was a very significant difference observed between IHC and GM staining, with a Z-score of − 7.066 and P < 0. The IHC showed a significantly higher mean rank of 79.32 compared to GM’s 35.68, indicating that IHC is more efficient than GM in identifying MCs in the peribronchial area. In the perialveolar area, no difference was found between IHC and TB staining, with a Z-score of 0.661 and P = −0.438. The mean ranks were 56.39 for IHC and 58.61 for TB, proving equal efficacy in MC visualization in this area.

Table 2.

The Mann hial tis U-test was employed to determine the differences in mast cell visualization between immunohistochemistry (CD117) and toluidine blue stain, as well as between immunohistochemistry (CD117) and Giemsa stain in mast cells located in the peribronchial and perialveolar regions of asphyxial fatalities

Region (mast cells) Staining method n Mean rank Z-score P
PB (mast cells) IHC mast cells 57 57.34 −0.051 <0.959
PB (mast cells) TB mast cells 57 57.66
Perialveolar (Mast cells) IHC mast cells 57 56.39 −0.438 <0.661
Perialveolar (mast cells) TB mast cells 57 58.61
PB (Mast cells) IHC mast cells 57 79.32 −7.066 <0.000
PB (mast cells) GM mast cells 57 35.68
Perialveolar (mast cells) IHC mast cells 57 64.57 −3.335 <0.001
Perialveolar (mast cells) GM mast cells 57 50.43

TB=Toluidine blue staining, IHC=Immunohistochemistry, PB=Peribronchial tissue, GM=Giemsa staining

Nevertheless, a significant difference was found between GM staining and IHC, with a Z-score of − 3.335 and P < 0.001. IHC yielded a higher mean rank of 64.57 compared to GM’s 50.43, suggesting that IHC is more effective than GM in visualizing perialveolar MCs. The Kruskal–Wallis test compares ordinal dependent variables across three or more groups in asphyxial and nonasphyxial parabronchial and perialveolar samples, demonstrating that GM stain differs significantly from TB and IHC. At the same time, TB and IHC show strong agreement, reinforcing that TB and IHC are more consistent and effective methods for identifying MCs in forensic lung tissue analysis [Table 3].

Table 3.

Immunohistochemistry, toluidine blue, and Giemsa stain mast cells P-substantial value in the peribronchial and perialveolar area of asphyxia and nonasphyxial deaths were calculated using the Kruskal–ruskal were

Stain/area Asphyxial samples (n) (PB) P (PB) Nonasphyxial samples (n) (PB) P (PB) Asphyxial Samples (n) (Perialveolar) P (perialveolar) Nonasphyxial samples (n) (perialveolar) P (perialveolar)
GM-TB 57 0.000 107 0.000 57 0.001 107 0.001
GM-IHC 57 0.000 107 0.000 57 0.003 107 0.002
TB-IHC 57 0.899 107 0.152 57 0.678 107 0.799

n=Number of samples from each lung, TB=Toluidine blue staining, IHC=Immunohistochemistry, GM=Giemsa staining, PB=Peribronchial tissue

Figure 1 shows the box and whisker plots for IHC, TB, and GM stain MCs in asphyxial patients for the peribronchial and perialveolar regions. Box and whisker plots for IHC, TB, and GM stain MCs in nonasphyxial patients are shown in Figure 2 for the peribronchial and perialveolar regions. The immunohistochemical technique using CD117 was used to selectively identify and visualize the peribronchial and perialveolar MCs, as shown by the red arrows [Figure 3]. The peribronchial and perialveolar MCs were highlighted with the TB stain [Figure 4] and the GM stain [Figure 5], as shown by the red arrow. The magnification for Figures 1-5 is ×400.

Figure 1.

Figure 1

Box and whisker plots for immunohistochemistry, Giemsa, and toluidine blue stain mast cells in asphyxial cases in the peribronchial and perialveolar region

Figure 2.

Figure 2

Box and whisker plots for immunohistochemistry, Giemsa, and toluidine blue stain mast cells in nonasphyxial cases in the peribronchial and perialveolar region

Figure 3.

Figure 3

Immunohistochemistry for CD117 highlights (a) peribronchial mast cells (red arrows), which should not be confounded with the coarse, dense anthracotic pigment seen in the image above the arrows, and (b) perialveolar mast cells (red arrows). These should not be confused with the alveolar macrophages, which have darker, coarse cytoplasmic pigment, ×400

Figure 4.

Figure 4

(a) Peribronchial mast cells and (b) Perialveolar mast cells are highlighted with the special stain toluidine blue (the red arrow); ×400

Figure 5.

Figure 5

(a) Peribronchial mast cells and (b) Perialveolar mast cells are highlighted with the special stain Giemsa stain (the red arrow, ×400)

DISCUSSION

In real-life forensic pathology practice, the conclusions regarding the cause and manner of death in cases of asphyxia have a potential direct effect on civil and criminal proceedings. In recent times, the research has focused on utilizing various techniques in cases of asphyxia, where the findings are nonspecific. Histochemical techniques and laboratory analysis play a crucial role in medicolegal investigations, serving as invaluable tools that are frequently essential in reaching a conclusive diagnosis, particularly in cases where there is no apparent macroscopic evidence.[,24,25] In this context, various research endeavors in clinical asphyxia have focused on understanding the precise role and functional implications of MCs in tissue remodeling processes.[26,27] Upon examination of the lungs of mice subjected to chronic hypoxia, Williams et al. discerned the existence of a heterogeneous assembly of MCs.[7,28]

A reduction in the level of inspired oxygen characterizes mechanical asphyxia.[29,30] Gutjahr and Madea found conventional and atypical hanging as a brief period of agony: following complete airway obstruction by an extrusion device, oxygen reserves are depleted at rest within 5 min. Prolonged asphyxia, observed in instances such as choking and strangling, was presumed in cases of partial airway obstruction or insufficiently inhibited respiratory movements, allowing for the inhalation of minimal oxygen quantities, hence extending survival to 12–15 min.[31] Studies have shown that MCs mediate the microvascular inflammatory changes in response to the systemic hypoxia produced due to low levels of inspired oxygen.[32] In the context of systemic hypoxia, there is an interaction between leukocytes and endothelial adhesion molecules. This interaction leads to leukocyte rolling and adherence within systemic venules, ultimately resulting in the migration of leukocytes into the surrounding tissue. In addition, during systemic hypoxia, an increase in vascular permeability to plasma proteins is observed.[4,33,34] This phenomenon is associated with the inflammatory response occurring at the microvascular level, mediated by MCs.[,36,37]

A range of methodologies has been utilized thus far for the identification and detection of MCs, encompassing both conventional techniques, such as special staining methods, such as TB and GM, as well as more advanced methodologies, including flow cytometry, IHC, enzyme-linked immunosorbent assay, reverse transcriptase polymerase chain reaction (RT-PCR), and spectroscopy.[13,39,40,41]

Steiner et al. provided compelling evidence supporting the role of MC activation in forming a chemotactic gradient during systemic hypoxia and its subsequent impact on microvascular inflammation. Their conclusion was drawn based on their observation that systemic hypoxia led to the degranulation of MCs, as evidenced by the increased uptake of ruthenium red by these cells. This indicated that MCs were undergoing degranulation, releasing their stored substances.[42,43] Reisinger et al. studied asphyxiation in badly deteriorated remains. The researchers examined tissues from 107 asphyxia-related fatalities using Oil Red O stain. Oil Red O stain histology showed tiny droplets of fatty degeneration.[44] Morphometric analysis examined pulmonary polynuclear large cells as a histological marker of asphyxiation.[29]

Previous investigations have undertaken numerous studies to identify MCs using GM and toluidine stains in different medical scenarios, including tumors, yielding notable findings.[13,39,46,47] Our study employed both of these staining approaches to detect MCs in mechanical asphyxia, an understudied condition. Our descriptive data show that asphyxia and nonasphyxial mortality differ in MC numbers in the perialveolar and peribronchial regions. MCs were examined using toluidine staining in the peribronchial area and found to be considerably higher in asphyxial deaths than in nonasphyxial deaths. MCs stained with GM stain showed no statistically substantial change in the average MC count in the same research sample.

Immunohistochemical methodologies have widespread applications across diverse research contexts, enabling the detection and investigation of cellular or tissue antigens, ranging from proteins to distinct populations of cells.[,48,49] In the context of mechanical asphyxia, several markers have been studied to date utilizing these techniques, such as hypoxia-inducible factor-1 (HIF-1), P-selectin, vascular endothelial growth factor, calbindin-D28K, GFAP, and vimentin.[11,50] Grellner et al. examined alveolar macrophages and pulmonary giant cells in lethal asphyxia. Six monoclonal antibodies were used for IHC on lung tissues from various lobes. The monoclonal antibodies including PG-M1 (for macrophage detection) and 25 F9 (for late-stage inflammation) showed positive immunohistochemical results. LN-4, 27 E10, AMH 152, and MIB 1 did not provide statistically substantial findings.[10] In the context of MCs, the HIF-1 is a pivotal regulator of the cellular response to hypoxic conditions.[51,52] It has been observed that HIF-1 expression is upregulated in human MCs in response to hypoxia.[,54,55,56,57,58]

In their original study, Cecchi et al. found HIF-1α, a subunit of HIF-1 (oxygen-sensitive, regulated by cellular oxygen levels), in the pulmonary arteries of suffocation victims. In their later analysis, they found HIF-1α expression in the pulmonary vasculature of suffocation victims. In several situations, CD117 + MCs colocalized with arteries that expressed HIF-1α. Hypoxia-induced HIF-1α expression in mast and endothelial cells. These findings provide a potential explanation for the observed quantitative increase in MCs and the notable elevation of HIF-1α expression in arteries of varying diameters, as previously reported.[3] In a similar study, Bogomolov et al. employed conventional histological and immunohistochemical techniques to examine the expression of the CD117 antigen. Their investigation revealed an upregulation of CD117 in lung tissue obtained from cases of mechanical strangulation asphyxia. However, they did not compare their findings with those using special stains and MCs in the peribronchial and perivascular regions of the lung.[,60,61]

In our study, the immunohistochemical analysis of MCs in the perialveolar and peribronchial region demonstrated a substantially higher mean MC count in cases of asphyxial fatalities than in nonasphyxial deaths. The present study’s findings on comparative analysis revealed that MCs stained with IHC and TB exhibited a substantially higher mean count in cases of asphyxial deaths than in nonasphyxial cases. On the other hand, MCs stained with GM showed a slightly higher mean count in asphyxial deaths, although the difference was not statistically significant. These results suggest MCs may play a role in the pathophysiological processes associated with asphyxial deaths. The differential response of MCs to different staining methods (TB vs. GM) indicates potential variations in their activation and degranulation patterns in asphyxiation-related conditions. Further investigation is warranted to elucidate the mechanisms underlying MC involvement in asphyxial deaths and determine the diagnostic and prognostic value of MC counts and activation patterns in forensic pathology.

CONCLUSION

In our research, we conducted a comparative analysis between the staining techniques, namely GM and TB. Our findings suggest that TB staining is superior to GM for detecting MCs in fatalities related to asphyxia. Upon further comparison, IHC techniques utilizing the CD117 marker yielded more specific information regarding the involvement of MCs in asphyxia-related alterations in lung tissue specimens compared to the aforementioned histological staining techniques, which is consistent with the findings of previous studies. Nevertheless, it is essential to contemplate the expensive cost of immunohistochemical techniques. Consequently, in resource-limited settings, special tissue staining methods can be utilized effectively for the characterization of MCs in asphyxia-related fatalities.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

The study was financially supported by the Intramural Project, All India Institute of Medical Sciences, Jodhpur, India.

REFERENCES

  • 1.Saukko P, Knight B. Knight's Forensic Pathology. 4th ed. Boca Raton (FL): CRC Press; 2016. [Google Scholar]
  • 2.Shkrum MJ, Ramsay DA. Forensic Pathology of Trauma. New York (NY): Springer Science and Business Media; 2007. [Google Scholar]
  • 3.Cecchi R, Sestili C, Prosperini G, Cecchetto G, Vicini E, Viel G, et al. Markers of mechanical asphyxia: Immunohistochemical study on autoptic lung tissues. Int J Legal Med. 2014;128:117–25. doi: 10.1007/s00414-013-0876-x. [DOI] [PubMed] [Google Scholar]
  • 4.Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LR, Mewburn JD, et al. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151:181–92. doi: 10.1016/j.chest.2016.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Maxová H, Bačáková L, Lisá V, Novotná J, Tomášová H, Vízek M, et al. Production of proteolytic enzymes in mast cells, fibroblasts, vascular smooth muscle and endothelial cells cultivated under normoxic or hypoxic conditions. Physiol Res. 2010;59:711–9. doi: 10.33549/physiolres.931909. [DOI] [PubMed] [Google Scholar]
  • 6.Kareinen I, Baumann M, Nguyen SD, Maaninka K, Anisimov A, Tozuka M, et al. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr (192) and compromises its cardioprotective activity. J Lipid Res. 2018;59:945–57. doi: 10.1194/jlr.M077503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang X, Lin L, Chai X, Wu Y, Li Y, Liu X. Hypoxic mast cells accelerate the proliferation, collagen accumulation and phenotypic alteration of human lung fibroblasts. Int J Mol Med. 2020;45:175–85. doi: 10.3892/ijmm.2019.4400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pejler G, Rönnberg E, Waern I, Wernersson S. Mast cell proteases: Multifaceted regulators of inflammatory disease. Blood. 2010;115:4981–90. doi: 10.1182/blood-2010-01-257287. [DOI] [PubMed] [Google Scholar]
  • 9.Kotani H, Miyao M, Manabe S, Ishida T, Kawai C, Abiru H, et al. Relationship of red splenic arteriolar hyaline with rapid death: A clinicopathological study of 82 autopsy cases. Diagn Pathol. 2012;7:182. doi: 10.1186/1746-1596-7-182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Grellner W, Madea B. Immunohistochemical characterization of alveolar macrophages and pulmonary giant cells in fatal asphyxia. Forensic Sci Int. 1996;79:205–13. doi: 10.1016/0379-0738(96)01913-5. [DOI] [PubMed] [Google Scholar]
  • 11.Salama M, Mohamed WM. Tau protein as a biomarker for asphyxia: A possible forensic tool? Appl Transl Genom. 2016;9:20–2. doi: 10.1016/j.atg.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhu BL, Ishida K, Fujita MQ, Maeda H. Immunohistochemical investigation of a pulmonary surfactant in fatal mechanical asphyxia. Int J Legal Med. 2000;113:268–71. doi: 10.1007/s004149900109. [DOI] [PubMed] [Google Scholar]
  • 13.Ribatti D. The staining of mast cells: A historical overview. Int Arch Allergy Immunol. 2018;176:55–60. doi: 10.1159/000487538. [DOI] [PubMed] [Google Scholar]
  • 14.Magaki S, Hojat SA, Wei B, So A, Yong WH. An introduction to the performance of immunohistochemistry. Methods Mol Biol. 2019:289–98. doi: 10.1007/978-1-4939-8935-5_25. 1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Foster BM, Zaidi D, Young TR, Mobley ME, Kerr BA. CD117/c-kit in cancer stem cell-mediated progression and therapeutic resistance. Biomedicines. 2018;6:31. doi: 10.3390/biomedicines6010031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Miettinen M, Lasota J. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205–20. doi: 10.1097/01.pai.0000173054.83414.22. [DOI] [PubMed] [Google Scholar]
  • 17.Shekhawat RS, Meshram VP, Rao M, Shedge R, Panwar R, Rathore M, et al. Further explorations into the role of mast cells in deaths associated with fatal asphyxia: An immunohistochemical study utilizing CD 117 marker. Forensic Sci Int. 2023;350:111689. doi: 10.1016/j.forsciint.2023.111689. [DOI] [PubMed] [Google Scholar]
  • 18.Muciaccia B, Sestili C, De Grossi S, Vestri A, Cipolloni L, Cecchi R. Are mast cells implicated in asphyxia? Int J Legal Med. 2016;130:153–61. doi: 10.1007/s00414-015-1211-5. [DOI] [PubMed] [Google Scholar]
  • 19.Ahmadi A, Poorfathollah AA, Aghaiipour M, Rezaei M, Nikoo-ghoftar M, Abdi M, et al. Diagnostic value of CD117 in differential diagnosis of acute leukemias. Tumour Biol. 2014;35:6763–8. doi: 10.1007/s13277-014-1899-8. [DOI] [PubMed] [Google Scholar]
  • 20.Myburgh R, Kiefer JD, Russkamp NF, Magnani CF, Nuñez N, Simonis A, et al. Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells. Leukemia. 2020;34:2688–703. doi: 10.1038/s41375-020-0818-9. [DOI] [PubMed] [Google Scholar]
  • 21.Expression of a Truncated Form of the c-Kit Tyrosine Kinase Receptor and Activation of Src Kinase in Human Prostatic Cancer - PubMed. [[Last accessed on 2023 Jul 06]]. Available from: https://pubmed.ncbi.nlm.nih.gov/15039213/ [DOI] [PMC free article] [PubMed]
  • 22.Immunohistochemical Studies of c-kit. Transforming Growth Factor-beta, and Basic Fibroblast Growth Factor in Mast Cell Disease - PubMed. [[Last accessed on 2023 Jul 06]]. Available from: https://pubmed.ncbi.nlm.nih.gov/11734306/ [DOI] [PubMed]
  • 23.Maghin F, Andreola SA, Boracchi M, Gentile G, Maciocco F, Muccino E, et al. Technical note: A histochemical approach in diagnosing hanging mechanical asphyxia on cadavers undergoing advanced putrefactive phenomena. Med Leg J. 2018;86:208–13. doi: 10.1177/0025817218764754. [DOI] [PubMed] [Google Scholar]
  • 24.Molina DK, Wood LE, Frost RE. Is routine histopathologic examination beneficial in all medicolegal autopsies? Am J Forensic Med Pathol. 2007;28:1–3. doi: 10.1097/01.paf.0000257388.83605.0a. [DOI] [PubMed] [Google Scholar]
  • 25.Singh D, Tiwari RC, Kumar A, Bhute AR, Meshram RP, Dikshit M, et al. A comprehensive review of pathological examination in forensic medicine: Past, present, and future. Cureus. 2022;14:e22740. doi: 10.7759/cureus.22740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Anand P, Singh B, Jaggi AS, Singh N. Mast cells: An expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:657–70. doi: 10.1007/s00210-012-0757-8. [DOI] [PubMed] [Google Scholar]
  • 27.Nuñez-Borque E, Fernandez-Bravo S, Yuste-Montalvo A, Esteban V. Pathophysiological, cellular, and molecular events of the vascular system in anaphylaxis. Front Immunol. 2022;13:836222. doi: 10.3389/fimmu.2022.836222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Williams A, Heath D, Kay JM, Smith P. Lung mast cells in rats exposed to acute hypoxia, and chronic hypoxia with recovery. Thora×. 1977;32:287–95. doi: 10.1136/thx.32.3.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mota-Rojas D, Villanueva-García D, Solimano A, Muns R, Ibarra-Ríos D, Mota-Reyes A. Pathophysiology of perinatal asphyxia in humans and animal models. Biomedicines. 2022;10:347. doi: 10.3390/biomedicines10020347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Park E, Liu E, Shemie SD, Baker AJ. Relating clinical and electrophysiological parameters in death determination in a laboratory model of progressive hypoxemia. Neurocrit Care. 2018;28:133–41. doi: 10.1007/s12028-017-0382-y. [DOI] [PubMed] [Google Scholar]
  • 31.Gutjahr E, Madea B. Inflammatory reaction patterns of the lung as a response to alveolar hypoxia and their significance for the diagnosis of asphyxiation. Forensic Sci Int. 2019;297:315–25. doi: 10.1016/j.forsciint.2019.02.026. [DOI] [PubMed] [Google Scholar]
  • 32.Möllerherm H, Branitzki-Heinemann K, Brogden G, Elamin AA, Oehlmann W, Fuhrmann H, et al. Hypoxia modulates the response of mast cells to Staphylococcus aureus infection. Front Immunol. 2017;8:541. doi: 10.3389/fimmu.2017.00541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rodriguez D, Watts D, Gaete D, Sormendi S, Wielockx B. Hypoxia pathway proteins and their impact on the blood vasculature. Int J Mol Sci. 2021;22:9191. doi: 10.3390/ijms22179191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Vajner L, Vytásek R, Lachmanová V, Uhlík J, Konrádová V, Novotná J, et al. Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats. Int J Exp Pathol. 2006;87:383–91. doi: 10.1111/j.1365-2613.2006.00493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, et al. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts. Theranostics. 2020;10:10743–68. doi: 10.7150/thno.46719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Matsuda K, Arkwright PD, Mori Y, Oikawa MA, Muko R, Tanaka A, et al. A rapid shift from chronic hyperoxia to normoxia induces systemic anaphylaxis via transient receptor potential ankyrin 1 channels on mast cells. J Immunol. 2020;205:2959–67. doi: 10.4049/jimmunol.2000149. [DOI] [PubMed] [Google Scholar]
  • 37.Gulliksson M, Carvalho RF, Ullerås E, Nilsson G. Mast cell survival and mediator secretion in response to hypoxia. PLoS One. 2010;5:e12360. doi: 10.1371/journal.pone.0012360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mutsaddi S, Kotrashetti VS, Nayak RS, Pattanshetty SM. Comparison of histochemical staining techniques for detecting mast cells in oral lesions. Biotech Histochem. 2019;94:459–68. doi: 10.1080/10520295.2019.1597986. [DOI] [PubMed] [Google Scholar]
  • 39.Grigorev IP, Korzhevskii DE. Modern imaging technologies of mast cells for biology and medicine (Review) Sovrem Tekhnologii Med. 2021;13:93–107. doi: 10.17691/stm2021.13.4.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhang K, Liu R, Tuo Y, Ma K, Zhang D, Wang Z, et al. Distinguishing asphyxia from sudden cardiac death as the cause of death from the lung tissues of rats and humans using fourier transform infrared spectroscopy. ACS Omega. 2022;7:46859–69. doi: 10.1021/acsomega.2c05968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Panwar R, Shekhawat RS, Shukla KK, Rao M, Rathore M, Kanchan T. Quantitative estimation of TNF-α and IL-3 by using ELISA from human lung tissue in fatal asphyxial deaths. J Forensic Leg Med. 2023;98:102559. doi: 10.1016/j.jflm.2023.102559. [DOI] [PubMed] [Google Scholar]
  • 42.Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol (1985) 2003;94:325–34. doi: 10.1152/japplphysiol.00637.2002. [DOI] [PubMed] [Google Scholar]
  • 43.Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: A multi-functional master cell. Front Immunol. 2015;6:620. doi: 10.3389/fimmu.2015.00620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Reisinger C, Sölkner J, Risser DU, Seltenhammer MH. Diagnosis of asphyxiation in advanced decomposed corpses by using Oil-Red-O Stain and immunohistochemical technology. Leg Med (Tokyo) 2023;62:102214. doi: 10.1016/j.legalmed.2023.102214. [DOI] [PubMed] [Google Scholar]
  • 45.Moradi Tabriz H, Obohat M, Vahedifard F, Eftekharjavadi A. Survey of mast cell density in transitional cell carcinoma. Iran J Pathol. 2021;16:119–27. doi: 10.30699/IJP.2020.123562.2345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Damsgaard TE, Olesen AB, Sørensen FB, Thestrup-Pedersen K, Schiøtz PO. Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res. 1997;289:256–60. doi: 10.1007/s004030050189. [DOI] [PubMed] [Google Scholar]
  • 47.Hsi. A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med. 2001;125:289–94. doi: 10.5858/2001-125-0289-APAFEN. [DOI] [PubMed] [Google Scholar]
  • 48.Leong AS, Wright J. The contribution of immunohistochemical staining in tumour diagnosis. Histopathology. 1987;11:1295–305. doi: 10.1111/j.1365-2559.1987.tb01874.x. [DOI] [PubMed] [Google Scholar]
  • 49.Brandtzaeg P. The increasing power of immunohistochemistry and immunocytochemistry. J Immunol Methods. 1998;216:49–67. doi: 10.1016/s0022-1759(98)00070-2. [DOI] [PubMed] [Google Scholar]
  • 50.Ortmann C, Brinkmann B. The expression of P-selectin in inflammatory and non-inflammatory lung tissue. Int J Legal Med. 1997;110:155–8. doi: 10.1007/s004140050055. [DOI] [PubMed] [Google Scholar]
  • 51.Ziello JE, Jovin IS, Huang Y. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 2007;80:51–60. [PMC free article] [PubMed] [Google Scholar]
  • 52.Branitzki-Heinemann K, Okumura CY, Völlger L, Kawakami Y, Kawakami T, Naim HY, et al. A novel role for the transcription factor HIF-1α in the formation of mast cell extracellular traps. Biochem J. 2012;446:159–63. doi: 10.1042/BJ20120658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Santoro P, La Russa R, Besi L, Voloninno G, dell’Aquila M, De Matties A, et al. The forensic approach to plastic bag suffocation: Case reports and review of the literature. Med Leg J. 2019;87:214–20. doi: 10.1177/0025817219861277. [DOI] [PubMed] [Google Scholar]
  • 54.Sobiepanek A, Kuryk Ł, Garofalo M, Kumar S, Baran J, Musolf P, et al. The multifaceted roles of mast cells in immune homeostasis, infections and cancers. Int J Mol Sci. 2022;23:2249. doi: 10.3390/ijms23042249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. [[Last accessed on 2023 Jul 11]];Front Immunol. 2018 9:1873. doi: 10.3389/fimmu.2018.01873. https://www.frontiersin.org/articles/10.3389/fimmu. 2018.01873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, et al. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth. Int J Cancer. 2013;132:2492–501. doi: 10.1002/ijc.27937. [DOI] [PubMed] [Google Scholar]
  • 57.Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, et al. Hypoxia-inducible factors: Master regulators of hypoxic tumor immune escape. J Hematol Oncol. 2022;15:77. doi: 10.1186/s13045-022-01292-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Walczak-Drzewiecka A, Ratajewski M, Wagner W, Dastych J. HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol. 2008;181:1665–72. doi: 10.4049/jimmunol.181.3.1665. [DOI] [PubMed] [Google Scholar]
  • 59.Bogomolov DV, Fetisov VA, Denisova OP, Zbrueva YV, Semenov GG. The principal and auxiliary immunohistochemical markers of intravital mechanical strangulation asphyxia. Sud Med Ekspert. 2018;61:11–3. doi: 10.17116/sudmed201861211-13. [DOI] [PubMed] [Google Scholar]
  • 60.Matos LL, Trufelli DC, de Matos MG, da Silva Pinhal MA. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20. doi: 10.4137/bmi.s2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kim SW, Roh J, Park CS. Immunohistochemistry for pathologists: Protocols, Pitfalls, and Tips. J Pathol Transl Med. 2016;50:411–8. doi: 10.4132/jptm.2016.08.08. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of African Medicine are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES